• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依帕司他通过减轻氧化应激和抑制多元醇通路来预防糖尿病周围神经病变。

Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway.

作者信息

Li Qing-Rong, Wang Zhuo, Zhou Wei, Fan Shou-Rui, Ma Run, Xue Li, Yang Lu, Li Ya-Shan, Tan Hong-Li, Shao Qing-Hua, Yang Hong-Ying

机构信息

Second Affiliated Hospital of Kunming Medical University, Department of Clinical Laboratory, Kunming, Yunnan Province, China.

Third People's Hospital of Yunnan Province, Kunming, Yunnan Province, China.

出版信息

Neural Regen Res. 2016 Feb;11(2):345-51. doi: 10.4103/1673-5374.177745.

DOI:10.4103/1673-5374.177745
PMID:27073391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4811002/
Abstract

Epalrestat is a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy. This study assumed that epalrestat had a protective effect on diabetic peripheral nerve injury by suppressing the expression of aldose reductase in peripheral nerves of diabetes mellitus rats. The high-fat and high-carbohydrate model rats were established by intraperitoneal injection of streptozotocin. Peripheral neuropathy occurred in these rats after sustaining high blood glucose for 8 weeks. At 12 weeks after streptozotocin injection, rats were intragastrically administered epalrestat 100 mg/kg daily for 6 weeks. Transmission electron microscope revealed that the injuries to myelinated nerve fibers, non-myelinated nerve fibers and Schwann cells of rat sciatic nerves had reduced compared to rats without epalrestat administuation. Western blot assay and immunohistochemical results demonstrated that after intervention with epalrestat, the activities of antioxidant enzymes such as superoxide dismutase, catalase and glutathione peroxidase gradually increased, but aldose reductase protein expression gradually diminished. Results confirmed that epalrestat could protect against diabetic peripheral neuropathy by relieving oxidative stress and suppressing the polyol pathway.

摘要

依帕司他是一种用于治疗糖尿病性神经病变的非竞争性可逆醛糖还原酶抑制剂。本研究假定依帕司他通过抑制糖尿病大鼠外周神经中醛糖还原酶的表达,对糖尿病性周围神经损伤具有保护作用。通过腹腔注射链脲佐菌素建立高脂高糖模型大鼠。这些大鼠在持续高血糖8周后出现周围神经病变。在注射链脲佐菌素12周后,大鼠每天灌胃给予依帕司他100 mg/kg,持续6周。透射电子显微镜显示,与未给予依帕司他的大鼠相比,大鼠坐骨神经的有髓神经纤维、无髓神经纤维和雪旺细胞的损伤有所减轻。蛋白质免疫印迹分析和免疫组化结果表明,依帕司他干预后,超氧化物歧化酶、过氧化氢酶和谷胱甘肽过氧化物酶等抗氧化酶的活性逐渐增加,但醛糖还原酶蛋白表达逐渐减少。结果证实,依帕司他可通过减轻氧化应激和抑制多元醇途径来预防糖尿病性周围神经病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/dfeaac2f4aca/NRR-11-345-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/52efe1f369a7/NRR-11-345-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/8801dfcaed54/NRR-11-345-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/6f46456e4955/NRR-11-345-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/c2cadac9fefb/NRR-11-345-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/dfeaac2f4aca/NRR-11-345-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/52efe1f369a7/NRR-11-345-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/8801dfcaed54/NRR-11-345-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/6f46456e4955/NRR-11-345-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/c2cadac9fefb/NRR-11-345-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f410/4811002/dfeaac2f4aca/NRR-11-345-g007.jpg

相似文献

1
Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway.依帕司他通过减轻氧化应激和抑制多元醇通路来预防糖尿病周围神经病变。
Neural Regen Res. 2016 Feb;11(2):345-51. doi: 10.4103/1673-5374.177745.
2
Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.醛糖还原酶抑制剂非达司他持续抑制外周神经中过多的多元醇途径通量可改善糖尿病性神经病变。
J Diabetes Complications. 1999 May-Jun;13(3):141-50. doi: 10.1016/s1056-8727(99)00038-0.
3
The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation.醛糖还原酶抑制剂依帕司他通过代谢调节对 db/db 小鼠糖尿病肾病发挥肾脏保护作用。
Acta Pharmacol Sin. 2019 Jan;40(1):86-97. doi: 10.1038/s41401-018-0043-5. Epub 2018 Jun 21.
4
Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor.醛糖还原酶抑制剂通过神经生长因子的合成/分泌对实验性糖尿病神经病变的治疗作用。
Exp Neurol. 1998 Jun;151(2):215-20. doi: 10.1006/exnr.1998.6821.
5
Pain Allaying Epalrestat-Loaded Lipid Nanoformulation for the Diabetic Neuropathic Pain Interventions: Design, Development, and Animal Study.用于糖尿病神经病理性疼痛干预的痛觉缓解依帕司他负载脂质纳米制剂的设计、开发和动物研究。
Curr Drug Metab. 2022;23(7):571-583. doi: 10.2174/1389200223666220810152633.
6
Treatment with NADPH oxidase inhibitor apocynin alleviates diabetic neuropathic pain in rats.用NADPH氧化酶抑制剂白杨素治疗可减轻大鼠糖尿病性神经病理性疼痛。
Neural Regen Res. 2018 Sep;13(9):1657-1664. doi: 10.4103/1673-5374.232530.
7
Neuroprotective effect of epalrestat mediated through oxidative stress markers, cytokines and TAU protein levels in diabetic rats.依帕司他通过氧化应激标志物、细胞因子和 Tau 蛋白水平对糖尿病大鼠的神经保护作用。
Life Sci. 2018 Aug 15;207:364-371. doi: 10.1016/j.lfs.2018.06.021. Epub 2018 Jun 21.
8
Lutein attenuates oxidative stress markers and ameliorates glucose homeostasis through polyol pathway in heart and kidney of STZ-induced hyperglycemic rat model.叶黄素通过多元醇途径减弱 STZ 诱导的糖尿病大鼠模型心脏和肾脏的氧化应激标志物,改善葡萄糖稳态。
Eur J Nutr. 2017 Dec;56(8):2475-2485. doi: 10.1007/s00394-016-1283-0. Epub 2016 Aug 3.
9
Cemtirestat, an aldose reductase inhibitor and antioxidant compound, induces ocular defense against oxidative and inflammatory stress in rat models for glycotoxicity.西替立肽,一种醛糖还原酶抑制剂和抗氧化化合物,可诱导大鼠糖毒性模型的眼部防御氧化和炎症应激。
Cell Biochem Funct. 2023 Aug;41(6):622-632. doi: 10.1002/cbf.3818. Epub 2023 Jun 5.
10
Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat.用于选择合适的糖尿病周围神经病变目标患者以接受醛糖还原酶抑制剂依帕司他长期治疗的分层分析。
Diabet Med. 2008 Jul;25(7):818-25. doi: 10.1111/j.1464-5491.2008.02490.x.

引用本文的文献

1
Microglial metabolic reprogramming: Aucubin inhibits aldose reductase to reverse diabetic neuropathic pain.小胶质细胞代谢重编程:桃叶珊瑚苷抑制醛糖还原酶以逆转糖尿病性神经病理性疼痛。
World J Diabetes. 2025 Aug 15;16(8):110285. doi: 10.4239/wjd.v16.i8.110285.
2
Modeling of Charcot-Marie-Tooth disease in zebrafish.斑马鱼中夏科-马里-图思病的建模
Front Mol Neurosci. 2025 Aug 4;18:1641793. doi: 10.3389/fnmol.2025.1641793. eCollection 2025.
3
Corrigendum: Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway.

本文引用的文献

1
[Protective effect of silibinin on islet β cells in C57BL/6J mice fed a highfat diet].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Feb;40(2):165-70. doi: 10.11817/j.issn.1672-7347.2015.02.008.
2
The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.氧化应激在糖尿病神经病变中的作用:糖基化反应中自由基的产生以及编码抗氧化酶的基因多态性与I型糖尿病患者群体对糖尿病神经病变的遗传易感性
Cell Biochem Biophys. 2015 Apr;71(3):1425-43. doi: 10.1007/s12013-014-0365-y.
3
Pathophysiology of diabetic retinopathy.糖尿病视网膜病变的病理生理学
勘误:依帕司他通过减轻氧化应激和抑制多元醇途径来预防糖尿病周围神经病变。
Neural Regen Res. 2026 Mar 1;21(3):922. doi: 10.4103/NRR.NRR-D-25-00562. Epub 2025 Jun 17.
4
Diabetic neuropathy: cutting-edge research and future directions.糖尿病神经病变:前沿研究与未来方向
Signal Transduct Target Ther. 2025 Apr 25;10(1):132. doi: 10.1038/s41392-025-02175-1.
5
Remodeling of the Intracardiac Ganglia During the Development of Cardiovascular Autonomic Dysfunction in Type 2 Diabetes: Molecular Mechanisms and Therapeutics.2 型糖尿病心血管自主神经功能障碍发展过程中心内神经节重塑:分子机制与治疗。
Int J Mol Sci. 2024 Nov 20;25(22):12464. doi: 10.3390/ijms252212464.
6
Bibliometric and visualized analysis of 2014-2024 publications on therapy for diabetic peripheral neuropathy.2014 - 2024年糖尿病周围神经病变治疗相关出版物的文献计量学与可视化分析
Front Neurosci. 2024 Nov 6;18:1434756. doi: 10.3389/fnins.2024.1434756. eCollection 2024.
7
Hydrogen sulfide alleviates neural degeneration probably by reducing oxidative stress and aldose reductase expression.硫化氢通过降低氧化应激和醛糖还原酶表达来减轻神经变性。
J Cell Mol Med. 2024 Nov;28(21):e70192. doi: 10.1111/jcmm.70192.
8
Transgenic zebrafish as a model for investigating diabetic peripheral neuropathy: investigation of the role of insulin signaling.转基因斑马鱼作为研究糖尿病周围神经病变的模型:胰岛素信号传导作用的研究
Front Cell Neurosci. 2024 Sep 24;18:1441827. doi: 10.3389/fncel.2024.1441827. eCollection 2024.
9
Proteomics-based screening of AKR1B1 as a therapeutic target and validation study for sepsis-associated acute kidney injury.基于蛋白质组学的 AKR1B1 作为治疗靶点的筛选及其在脓毒症相关性急性肾损伤中的验证研究。
PeerJ. 2024 Jan 2;12:e16709. doi: 10.7717/peerj.16709. eCollection 2024.
10
Key Therapeutic Targets to Treat Hyperglycemia-Induced Atherosclerosis Analyzed Using a Petri Net-Based Model.使用基于Petri网的模型分析治疗高血糖诱导动脉粥样硬化的关键治疗靶点。
Metabolites. 2023 Dec 8;13(12):1191. doi: 10.3390/metabo13121191.
ISRN Ophthalmol. 2013 Jan 15;2013:343560. doi: 10.1155/2013/343560. eCollection 2013.
4
Diabetic peripheral neuropathy: current perspective and future directions.糖尿病周围神经病变:当前观点与未来方向
Pharmacol Res. 2014 Feb;80:21-35. doi: 10.1016/j.phrs.2013.12.005. Epub 2013 Dec 25.
5
Do plants mediate their anti-diabetic effects through anti-oxidant and anti-apoptotic actions? an in vitro assay of 3 Indian medicinal plants.植物是否通过抗氧化和抗细胞凋亡作用来发挥其抗糖尿病作用?3 种印度药用植物的体外试验。
BMC Complement Altern Med. 2013 Oct 5;13:257. doi: 10.1186/1472-6882-13-257.
6
Increased Serum Cu/Zn SOD in Individuals with Clinical Depression Normalizes After Zinc and Anti-oxidant Therapy.临床抑郁症患者血清铜/锌超氧化物歧化酶水平升高,经锌和抗氧化剂治疗后恢复正常。
Nutr Metab Insights. 2010 Jun 17;3:37-42. doi: 10.4137/NMI.S5044. eCollection 2010.
7
Biology of diabetic neuropathy.糖尿病性神经病变的生物学
Handb Clin Neurol. 2013;115:591-606. doi: 10.1016/B978-0-444-52902-2.00034-5.
8
Diabetic neuropathy and oxidative stress: therapeutic perspectives.糖尿病神经病变与氧化应激:治疗展望。
Oxid Med Cell Longev. 2013;2013:168039. doi: 10.1155/2013/168039. Epub 2013 Apr 24.
9
[The role of iron metabolism and oxidative stress in the pathogenesis of endometriosis].
Ginekol Pol. 2013 Jan;84(1):62-4. doi: 10.17772/gp/1542.
10
Long-term streptozotocin-induced diabetes in rats leads to severe damage of brain blood vessels and neurons via enhanced oxidative stress.长期链脲佐菌素诱导的糖尿病大鼠通过增强氧化应激导致脑血管和神经元严重损伤。
Mol Med Rep. 2013 Feb;7(2):431-40. doi: 10.3892/mmr.2012.1227. Epub 2012 Dec 10.